Masahiro Kamaura

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Kamaura. Retrieved from https://idiyas.com/inventor/masahiro-kamaura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 1)

% Patents Active = 40.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 36(Granted Patents)

Location History:

Osaka, JP (2012 - 2016)
Kanagawa, JP (2018 - 2021)

Company Filing History:

10 out of 1,228

Takeda Pharmaceutical Company Limited

patents

Years Active: 2012-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10975043 - Heterocyclic compound (2021-04-13),

2. 10544111 - Heterocyclic compound (2020-01-28),

3. 10214498 - Heterocyclic compound (2019-02-26),

4. 9975903 - Condensed heterocyclic compound (2018-05-22),

5. 9944596 - Heterocyclic compound (2018-04-17),

6. 9487509 - Heterocyclic compound (2016-11-08),

7. 8586571 - Heterocyclic compound (2013-11-19),

8. 8410089 - Fused heterocyclic ring compound (2013-04-02),

9. 8383647 - Quinoline derivative (2013-02-26),

10. 8338622 - Heterocyclic compound (2012-12-25),

Title: The Innovative Journey of Masahiro Kamaura: Pushing Technological Boundaries in Kanagawa

Introduction:

Masahiro Kamaura, a visionary inventor hailing from Kanagawa, JP, is a standout figure in the world of innovation. His inventive spirit and dedication to pushing the boundaries of technology have not only advanced industries but have also inspired the next generation of inventors to dream big and create the future.

Latest Patents:

Having amassed an impressive portfolio of 10 patents, Masahiro Kamaura's latest inventions include heterocyclic compounds with superior RBP4-lowering action. These compounds hold significant promise as medicaments for the prophylaxis or treatment of diseases or symptoms mediated by an increase in RBP4 or retinol supplied by RBP4.

Career Highlights:

Currently, Masahiro Kamaura is making waves in the field of pharmaceuticals as a key member of the renowned Takeda Pharmaceutical Company Limited. His innovative solutions are shaping the future of healthcare and making a tangible impact on the lives of many.

Collaborations:

Within Takeda Pharmaceutical Company Limited, Masahiro Kamaura collaborates closely with esteemed coworkers such as Yoshihiro Banno and Kazuaki Takami. Together, they form a dynamic team dedicated to driving innovation and bringing groundbreaking ideas to fruition.

Conclusion:

In conclusion, Masahiro Kamaura's unwavering commitment to innovation and his trailblazing inventions have cemented his legacy as a pioneering force in the world of technology. His work not only transforms industries but also serves as a beacon of inspiration for aspiring inventors worldwide, urging them to dare to dream and shape a brighter tomorrow.

Profile summary based on public USPTO records.